Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UCD19 CAR-T in Pediatric B-ALL and B-NHL
NCT04544592Phase 2Recruiting
- Sponsor
- University of Colorado Denver
- Start
- Mar 2021
- Primary completion
- Mar 2030
- Modality
- Gene Editing, Gene Silencing, CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of UCD19 CAR-T in B cell acute lymphoblastic leukemia (B-ALL), B-cell non-Hodgkin lymphoma, sponsored by University of Colorado Denver. Started Mar 2021; status: recruiting.
02
Drugs
UCD19 CAR-T
03
Conditions
B cell acute lymphoblastic leukemia (B-ALL)B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT04544592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04544592.